5.39
price up icon2.28%   0.12
after-market Dopo l'orario di chiusura: 5.39
loading

Foghorn Therapeutics Inc Azioni (FHTX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
26.97%
7.557
5.952 2.856 7.808 6.888
Operating Expenses
0.73%
28.65
28.86 26.86 31.66 33.52
Benefits Costs and Expenses
-
- 22.36 26.93 29.87
Costs And Expenses
0.73%
28.65
28.86 22.36 26.93 29.87
Operating Income/Loss
7.93%
-21.10
-22.91 -24.00 -23.85 -26.63
Nonoperating Income/Loss
22.51%
3.161
4.079 4.502 4.73 3.653
Income/Loss From Continuing Operations Before Tax
140.12%
7.557
-18.83 -19.50 -19.12 -22.98
Income/Loss From Continuing Operations After Tax
4.77%
-17.94
-18.83 -19.50 -19.12 -22.98
Net Income/Loss
4.77%
-17.94
-18.83 -19.50 -19.12 -22.98
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.21%
62.98
62.85 2.6575 62.60 51.58
Diluted Average Shares
0.21%
62.98
62.85 2.6575 62.60 51.58
Basic Earnings Per Share
6.67%
-0.28
-0.30 -0.30 -0.31 -0.45
Diluted Earnings Per Share
6.67%
-0.28
-0.30 -0.30 -0.31 -0.45
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Capitalizzazione:     |  Volume (24 ore):